WCG
VCYT icon

Weaver Consulting Group’s Veracyte VCYT Stock Holding History

Weaver Consulting Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$16K – 874
2020
Q3 		$16K Hold
500
– – 0.01% 454
2020
Q2 		$13K Buy
+500
New +$12.5K 0.01% 475

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Weaver Consulting Group's VCYT Position: Q4 2020 in Review

Weaver Consulting Group sold out of Veracyte (VCYT) in Q4 2020, closing a stake of 500 shares — an estimated $16K sold.

Weaver Consulting Group first reported a position in VCYT in Q2 2020 and held it in 2 quarters. The position peaked at $16K in Q3 2020. 222 funds tracked by Wall St. Rank hold VCYT as of Q4 2020.

  • Weaver Consulting Group reported no remaining Veracyte position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 500 Veracyte shares in Q4 2020, an estimated $16K.
  • Weaver Consulting Group first reported a position in Veracyte in Q2 2020 and held it in 2 quarters.
  • Weaver Consulting Group's Veracyte position peaked at $16K in Q3 2020.
  • 222 funds tracked by Wall St. Rank held Veracyte as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.